About Minster Pharmaceuticals
Minster Pharmaceuticals is a Healthcare company based in London (United Kingdom) founded in 2001, and was acquired by Proximagen in January 2010. Therapeutics for CNS disorders including migraine were developed. The company was acqui-hired. Its focus areas include Life Sciences, Pain Management, Drugs and Diversified.
Company details
Minster Pharmaceuticals was established in 2001 in London, United Kingdom, within the pharmaceutical sector. Focus was placed on developing treatments for central nervous system conditions, particularly migraine. Operations centered on advancing drug candidates through clinical trials. The lead product, tonabersat, underwent Phase 3 evaluation but did not succeed in February 2009. Acquisition by Proximagen occurred in January 2010, concluding independent activities.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website minsterpharma.com
- Acquired by Proximagen (Jan 2010)
- Investors
- Acquired byProximagen
(Jan 2010)
Investors in Minster Pharmaceuticals
Minster Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Proximagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Small molecules for neurodegenerative disorders, including Parkinson’s and Alzheimers. | 2004 | proximagen.com | London, United Kingdom |
Investor details for Minster Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Minster Pharmaceuticals
2 dated milestones of Minster Pharmaceuticals across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Minster Pharmaceuticals is founded.
- Exit Acquired by Proximagen.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Minster Pharmaceuticals
Minster Pharmaceuticals was founded in 2001.
Minster Pharmaceuticals is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Minster Pharmaceuticals was established in 2001 in London, United Kingdom, within the pharmaceutical sector. Focus was placed on developing treatments for central nervous system conditions, particularly migraine. Operations centered on advancing drug candidates through clinical trials. The lead product, tonabersat, underwent Phase 3 evaluation but did not succeed in February 2009. Acquisition by Proximagen occurred in January 2010, concluding independent activities.
Minster Pharmaceuticals has 1 investor. Key investors include Proximagen.
Yes. Minster Pharmaceuticals was acquired by Proximagen in January 2010.